Quercetin inhibits advanced glycation end product formation by trapping methylglyoxal and glyoxal

Journal of Agricultural and Food Chemistry

Volumn 62, Issue 50, 2014, Pages 12152-12158

  Li, Xiaoming ^a   Zheng, Tiesong ^a   Sang, Shengmin ^b   Lv, Lishuang ^a  

^a NANJING NORMAL UNIVERSITY   (China)

^b NORTH CAROLINA A AND T STATE UNIVERSITY   (United States)

Author keywords

Advanced glycation end products (AGEs); Diabetic complications; Glyoxal; Methylglyoxal; Quercetin

Indexed keywords

BODY FLUIDS; GLYCOSYLATION; PHENOLS;

ADVANCED GLYCATION END PRODUCTS; DIABETIC COMPLICATIONS; GLYOXAL; METHYLGLYOXAL; QUERCETIN;

FLAVONOIDS;

BOVINAE;

ADVANCED GLYCATION END PRODUCT; BOVINE SERUM ALBUMIN; GLYOXAL; METHYLGLYOXAL; QUERCETIN;

ANIMAL; BOVINE; CHEMICAL STRUCTURE; CHEMISTRY;

ANIMALS; CATTLE; GLYCOSYLATION END PRODUCTS, ADVANCED; GLYOXAL; MOLECULAR STRUCTURE; PYRUVALDEHYDE; QUERCETIN; SERUM ALBUMIN, BOVINE;

EID: 84918589146     PISSN: 00218561     EISSN: 15205118     Source Type: Journal    
DOI: 10.1021/jf504132x     Document Type: Article

References (41)

1. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. New Engl. J. Med. 1993, 329, 977-986.
2. Ahmed, N. Advanced glycation endproducts - role in pathology of diabetic complications. Diabetes Res. Clin. Practice 2005, 67, 3-21.
3. Vlassara, H.; Palace, M. R. Diabetes and advanced glycation endproducts. J. Intern. Med. 2002, 251, 87-101.
4. Wu, C.-H.; Huang, S.-M.; Lin, J.-A.; Yen, G.-C. Inhibition of advanced glycation endproduct formation by foodstuffs. Food Funct. 2011, 2, 224-234.
5. Thornalley, P. J. Use of aminoguanidine (Pimagedine) to prevent the formation of advanced glycation endproducts. Arch. Biochem. Biophys. 2003, 419, 31-40.
6. Brownlee, M. Advanced protein glycosylation in diabetes and aging. Annu. Rev. Med. 1995, 46, 223-234.
7. Shibamoto, T. Analytical methods for trace levels of reactive carbonyl compounds formed in lipid peroxidation systems. J. Pharm. Biomed. Anal. 2006, 41, 12-25.
8. Aldini, G.; Dalle-Donne, I.; Facino, R. M.; Milzani, A.; Carini, M. Intervention strategies to inhibit protein carbonylation by lipoxidation-derived reactive carbonyls. Med. Res. Rev. 2007, 27, 817-868.
9. Beisswenger, P.; Howell, S.; Nelson, R.; Mauer, M.; Szwergold, B. α-Oxoaldehyde metabolism and diabetic complications. Biochem. Soc. Trans. 2003, 31, 1358-1363.
10. Lo, T.; Westwood, M. E.; McLellan, A. C.; Selwood, T.; Thornalley, P. J. Binding and modification of proteins by methylglyoxal under physiological conditions. A kinetic and mechanistic study with N-α-acetylarginine, N-α-acetylcysteine, and N-α-acetyllysine, and bovine serum albumin. J. Biol. Chem. 1994, 269, 32299-32305.
11. Shamsi, F. A.; Partal, A.; Sady, C.; Glomb, M. A.; Nagaraj, R. H. Immunological evidence for methylglyoxal-derived modifications in vivo determination of antigenic epitopes. J. Biol. Chem. 1998, 273, 6928-6936.
12. Klöpfer, A.; Spanneberg, R.; Glomb, M. A. Formation of arginine modifications in a model system of N-α-tert-butoxycarbonyl (Boc)-arginine with methylglyoxal. J. Agric. Food Chem. 2010, 59, 394-401.
13. Gao, Y.; Wang, Y. Site-selective modifications of arginine residues in human hemoglobin induced by methylglyoxal. Biochemistry 2006, 45, 15654-15660.
14. Kang, J. H. Oxidative damage of DNA induced by methylglyoxal in vitro. Toxicology Lett. 2003, 145, 181-187.
15. Kilhovd, B. K.; Juutilainen, A.; Lehto, S.; Rönnemaa, T.; Torjesen, P. A.; Hanssen, K. F.; Laakso, M. Increased serum levels of methylglyoxal-derived hydroimidazolone-AGE are associated with increased cardiovascular disease mortality in nondiabetic women. Atherosclerosis 2009, 205, 590-594.
16. Thomas, M.; Baynes, J.; Thorpe, S.; Cooper, M. The role of AGEs and AGE inhibitors in diabetic cardiovascular disease. Curr. Drug Targets 2005, 6, 453-474.
17. Cervantes-Laurean, D.; Schramm, D. D.; Jacobson, E. L.; Halaweish, I.; Bruckner, G. G.; Boissonneault, G. A. Inhibition of advanced glycation end product formation on collagen by rutin and its metabolites. J. Nutr. Biochem. 2006, 17, 531-540.
18. Peyroux, J.; Sternberg, M. Advanced glycation endproducts (AGEs): pharmacological inhibition in diabetes. Pathol. Biol. 2006, 54, 405-419.
19. Webster, J.; Urban, C.; Berbaum, K.; Loske, C.; Alpar, A.; Gärtner, U.; De Arriba, S. G.; Arendt, T.; Münch, G. The carbonyl scavengers aminoguanidine and tenilsetam protect against the neurotoxic effects of methylglyoxal. Neurotoxicity Res. 2005, 7, 95-101.
20. Schurman, L.; McCarthy, A.; Sedlinsky, C.; Gangoiti, M.; Arnol, V.; Bruzzone, L.; Cortizo, A. Metformin reverts deleterious effects of advanced glycation end-products (AGEs) on osteoblastic cells. Exp. Clin. Endocrinol. Diabetes 2008, 116, 333-340.
21. Beisswenger, P.; Ruggiero-Lopez, D. Metformin inhibition of glycation processes. Diabetes Metab. 2003, 29, 6S95-6S103.
22. Price, D. L.; Rhett, P. M.; Thorpe, S. R.; Baynes, J. W. Chelating activity of advanced glycation end-product inhibitors. J. Biol. Chem. 2001, 276, 48967-48972.
23. Romagnolo, D. F.; Selmin, O. I. Flavonoids and cancer prevention: a review of the evidence. J. Nutr. Gerontol. Geriatrics 2012, 31, 206-238.
24. Morimitsu, Y.; Yoshida, K.; Esaki, S.; Hirota, A. Protein glycation inhibitors from thyme (Thymus vulgaris ). Biosci., Biotechnol., Biochem. 1995, 59, 2018-2021.
25. Lv, L.; Shao, X.; Chen, H.; Ho, C.-T.; Sang, S. Genistein inhibits advanced glycation end product formation by trapping methylglyoxal. Chem. Res. Toxicol. 2011, 24, 579-586.
26. Sang, S.; Shao, X.; Bai, N.; Lo, C.-Y.; Yang, C. S.; Ho, C.-T. Tea polyphenol (-)-epigallocatechin-3-gallate: a new trapping agent of reactive dicarbonyl species. Chem. Res. Toxicol. 2007, 20, 1862-1870.
27. Shao, X.; Bai, N.; He, K.; Ho, C.-T.; Yang, C. S.; Sang, S. Apple polyphenols, phloretin and phloridzin: new trapping agents of reactive dicarbonyl species. Chem. Res. Toxicol. 2008, 21, 2042-2050.
28. Wang, W.; Yagiz, Y.; Buran, T. J.; Nunes, C. d. N.; Gu, L. Phytochemicals from berries and grapes inhibited the formation of advanced glycation end-products by scavenging reactive carbonyls. Food Res. Int. 2011, 44, 2666-2673.
29. Sengupta, B.; Uematsu, T.; Jacobsson, P.; Swenson, J. Exploring the antioxidant property of bioflavonoid quercetin in preventing DNA glycation: a calorimetric and spectroscopic study. Biochem. Biophys. Res. Commun. 2006, 339, 355-361.
30. Wang, Y.; Ho, C. T. Flavour chemistry of methylglyoxal and glyoxal. Chem. Soc. Rev. 2012, 41, 4140-4149.
31. Hsieh, C.-L.; Lin, Y.-C.; Yen, G.-C.; Chen, H.-Y. Preventive effects of guava (Psidium guajava L.) leaves and its active compounds against α-dicarbonyl compounds-induced blood coagulation. Food Chem. 2007, 103, 528-535.
32. Lee, O.; Bruce, W. R.; Dong, Q.; Bruce, J.; Mehta, R.; O'Brien, P. J. Fructose and carbonyl metabolites as endogenous toxins. Chem.-Biol. Interact. 2009, 178, 332-339.
33. European Commission. Scientific Committee on Consumer Products (SCCP) Opinion on Glyoxal, the 4th plenary of June 2005, http://ec.europa.eu/health/ph-risk/committees/04-sccp/docs/sccp-o-023.pdf.
34. Sadowska-Bartosz, I.; Galiniak, S.; Bartosz, G. Kinetics of glycoxidation of bovine serum albumin by methylglyoxal and glyoxal and its prevention by various compounds. Molecules 2014, 19, 4880-4896.
35. Peng, X.; Cheng, K.-W.; Ma, J.; Chen, B.; Ho, C.-T.; Lo, C.; Chen, F.; Wang, M. Cinnamon bark proanthocyanidins as reactive carbonyl scavengers to prevent the formation of advanced glycation endproducts. J. Agric. Food Chem. 2008, 56, 1907-1911.
36. Shao, X.; Chen, H.; Zhu, Y.; Sedighi, R.; Ho, C.-T.; Sang, S. Essential structural requirements and additive effects for flavonoids to scavenge methylglyoxal. J. Agric. Food Chem. 2014, 62, 3202-3210.
37. Hertog, M. G.; Hollman, P. C.; Katan, M. B.; Kromhout, D. Intake of potentially anticarcinogenic flavonoids and their determinants in adults in The Netherlands. Nutr. Cancer 1993, 20, 21-29.
38. Afanas'ev, I. B.; Dcrozhko, A. I.; Brodskii, A. V.; Kostyuk, V. A.; Potapovitch, A. I. Chelating and free radical scavenging mechanisms of inhibitory action of rutin and quercetin in lipid peroxidation. Biochem. Pharmacol. 1989, 38, 1763-1769.
39. Murray, M. Quercetin: nature's antihistamine. Better Nutr. 1998, 60, 10-14.
40. Comalada, M.; Camuesco, D.; Sierra, S.; Ballester, I.; Xaus, J.; Galvez, J.; Zarzuelo, A. In vivo quercitrin anti-inflammatory effect involves release of quercetin, which inhibits inflammation through down-regulation of the NF-κB pathway. Eur. J. Immunol. 2005, 35, 584-592.
41. Wu, C. H.; Yen, G. C. Inhibitory effect of naturally occurring flavonoids on the formation of advanced glycation endproducts. J. Agric. Food Chem. 2005, 53, 3167-3173.